Mucinex DM Maximum Strength Tablets from Canada
Extended-release tablets combining guaifenesin as expectorant and dextromethorphan as cough suppressant to thin mucus and control cough. Packaged in measured doses for retail sale, it targets respiratory symptoms, fitting HTS 3004.90.92.68 for cough and cold preparations.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide stability data and dissolution profiles for extended-release formulations
• Ensure child-resistant packaging complies with U.S
• Poison Prevention Act
• Confirm no prohibited substances to prevent FDA import alerts